The priority review voucher: a misconceived quid pro quo

. 2024 Dec 3;9(12):e015933.

doi: 10.1136/bmjgh-2024-015933.

Affiliations

¹ ISARIC, Pandemic Sciences Institute, Nufflield Departmente of Medicine, University of Oxford, Oxford, UK piero.olliaro@ndm.ox.ac.uk.
² Independent Researcher, Geneva, Switzerland.

Piero Olliaro et al. BMJ Glob Health. 2024.

. 2024 Dec 3;9(12):e015933.

doi: 10.1136/bmjgh-2024-015933.

¹ ISARIC, Pandemic Sciences Institute, Nufflield Departmente of Medicine, University of Oxford, Oxford, UK piero.olliaro@ndm.ox.ac.uk.
² Independent Researcher, Geneva, Switzerland.

No abstract available

Keywords: Global Health; Public Health.

Conflict of interest statement

Competing interests: None declared.

Cholera vaccines for the rich, cholera for the poor: While the global cholera vaccine stockpile runs dry, a booming market for high-income countries exemplifies the chasm between commercial interests and global health needs.
Houston AR, Houston S. Houston AR, et al. PLOS Glob Public Health. 2025 Mar 24;5(3):e0004359. doi: 10.1371/journal.pgph.0004359. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 40127056 Free PMC article. No abstract available.

1. Suleman F, Low M, Moon S, et al. New business models for research and development with affordability requirements are needed to achieve fair pricing of medicines. BMJ. 2020;368:l4408. doi: 10.1136/bmj.l4408. - DOI - PubMed
1. Ridley DB, Grabowski HG, Moe JL. Developing drugs for developing countries. Health Aff (Millwood) 2006;25:313–24. doi: 10.1377/hlthaff.25.2.313. - DOI - PubMed
1. U. S. Government Accountability Office Drug development: fda’s priority review voucher programs. 2020. https://www.gao.gov/products/gao-20-251 Available.
1. Ridley DB, Lasanta AM, Storer Jones F, et al. European priority review vouchers for neglected disease product development. BMJ Glob Health. 2024;9:e013686. doi: 10.1136/bmjgh-2023-013686. - DOI - PMC - PubMed
1. Aerts C, Barrenho E, Miraldo M, et al. The Impact of the Priority Review Voucher on Research and Development for Tropical Diseases. Pharm Med. 2022;36:189–97. doi: 10.1007/s40290-022-00427-x. - DOI - PMC - PubMed